Literature DB >> 26113416

NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features.

Marlise R Luskin1, Auris O Huen2, Sarah A Brooks3, Campbell Stewart2, Christopher D Watt3, Jennifer J D Morrissette3, David B Lieberman3, Adam Bagg3, Misha Rosenbach2, Alexander E Perl4.   

Abstract

Entities:  

Keywords:  AML; NPM1; leukemia cutis; next generation sequencing; nucleophosmin

Mesh:

Substances:

Year:  2015        PMID: 26113416      PMCID: PMC4591778          DOI: 10.3324/haematol.2015.129346

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis.

Authors:  H Agis; A Weltermann; C Fonatsch; O Haas; G Mitterbauer; L Müllauer; S Schreiber; I Schwarzinger; W Juretzka; P Valent; U Jäger; K Lechner; K Geissler
Journal:  Ann Hematol       Date:  2002-01-23       Impact factor: 3.673

2.  How I treat extramedullary acute myeloid leukemia.

Authors:  Richard L Bakst; Martin S Tallman; Dan Douer; Joachim Yahalom
Journal:  Blood       Date:  2011-07-27       Impact factor: 22.113

3.  Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Authors:  Jay P Patel; Mithat Gönen; Maria E Figueroa; Hugo Fernandez; Zhuoxin Sun; Janis Racevskis; Pieter Van Vlierberghe; Igor Dolgalev; Sabrena Thomas; Olga Aminova; Kety Huberman; Janice Cheng; Agnes Viale; Nicholas D Socci; Adriana Heguy; Athena Cherry; Gail Vance; Rodney R Higgins; Rhett P Ketterling; Robert E Gallagher; Mark Litzow; Marcel R M van den Brink; Hillard M Lazarus; Jacob M Rowe; Selina Luger; Adolfo Ferrando; Elisabeth Paietta; Martin S Tallman; Ari Melnick; Omar Abdel-Wahab; Ross L Levine
Journal:  N Engl J Med       Date:  2012-03-14       Impact factor: 91.245

4.  DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia.

Authors:  Alison R Sehgal; Phyllis A Gimotty; Jianhua Zhao; Jing-Mei Hsu; Robert Daber; Jennifer D Morrissette; Selina Luger; Alison W Loren; Martin Carroll
Journal:  Clin Cancer Res       Date:  2015-01-21       Impact factor: 12.531

5.  The prognostic relevance of flt3 and npm1 mutations on older patients treated intensively or non-intensively: a study of 1312 patients in the UK NCRI AML16 trial.

Authors:  M Lazenby; A F Gilkes; C Marrin; A Evans; R K Hills; A K Burnett
Journal:  Leukemia       Date:  2014-02-27       Impact factor: 11.528

6.  Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.

Authors:  Jan Krönke; Lars Bullinger; Veronica Teleanu; Florian Tschürtz; Verena I Gaidzik; Michael W M Kühn; Frank G Rücker; Karlheinz Holzmann; Peter Paschka; Silke Kapp-Schwörer; Daniela Späth; Thomas Kindler; Marcus Schittenhelm; Jürgen Krauter; Arnold Ganser; Gudrun Göhring; Brigitte Schlegelberger; Richard F Schlenk; Hartmut Döhner; Konstanze Döhner
Journal:  Blood       Date:  2013-05-23       Impact factor: 22.113

Review 7.  Leukemia cutis.

Authors:  K V Ratnam; C J Khor; W P Su
Journal:  Dermatol Clin       Date:  1994-04       Impact factor: 3.478

8.  Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas.

Authors:  B Falini; D Lenze; R Hasserjian; S Coupland; D Jaehne; C Soupir; A Liso; M P Martelli; N Bolli; F Bacci; V Pettirossi; A Santucci; M F Martelli; S Pileri; H Stein
Journal:  Leukemia       Date:  2007-04-19       Impact factor: 11.528

9.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Authors:  Timothy J Ley; Christopher Miller; Li Ding; Benjamin J Raphael; Andrew J Mungall; A Gordon Robertson; Katherine Hoadley; Timothy J Triche; Peter W Laird; Jack D Baty; Lucinda L Fulton; Robert Fulton; Sharon E Heath; Joelle Kalicki-Veizer; Cyriac Kandoth; Jeffery M Klco; Daniel C Koboldt; Krishna-Latha Kanchi; Shashikant Kulkarni; Tamara L Lamprecht; David E Larson; Ling Lin; Charles Lu; Michael D McLellan; Joshua F McMichael; Jacqueline Payton; Heather Schmidt; David H Spencer; Michael H Tomasson; John W Wallis; Lukas D Wartman; Mark A Watson; John Welch; Michael C Wendl; Adrian Ally; Miruna Balasundaram; Inanc Birol; Yaron Butterfield; Readman Chiu; Andy Chu; Eric Chuah; Hye-Jung Chun; Richard Corbett; Noreen Dhalla; Ranabir Guin; An He; Carrie Hirst; Martin Hirst; Robert A Holt; Steven Jones; Aly Karsan; Darlene Lee; Haiyan I Li; Marco A Marra; Michael Mayo; Richard A Moore; Karen Mungall; Jeremy Parker; Erin Pleasance; Patrick Plettner; Jacquie Schein; Dominik Stoll; Lucas Swanson; Angela Tam; Nina Thiessen; Richard Varhol; Natasja Wye; Yongjun Zhao; Stacey Gabriel; Gad Getz; Carrie Sougnez; Lihua Zou; Mark D M Leiserson; Fabio Vandin; Hsin-Ta Wu; Frederick Applebaum; Stephen B Baylin; Rehan Akbani; Bradley M Broom; Ken Chen; Thomas C Motter; Khanh Nguyen; John N Weinstein; Nianziang Zhang; Martin L Ferguson; Christopher Adams; Aaron Black; Jay Bowen; Julie Gastier-Foster; Thomas Grossman; Tara Lichtenberg; Lisa Wise; Tanja Davidsen; John A Demchok; Kenna R Mills Shaw; Margi Sheth; Heidi J Sofia; Liming Yang; James R Downing; Greg Eley
Journal:  N Engl J Med       Date:  2013-05-01       Impact factor: 91.245

Review 10.  Leukemia cutis.

Authors:  Jeong Hee Cho-Vega; L Jeffrey Medeiros; Victor G Prieto; Francisco Vega
Journal:  Am J Clin Pathol       Date:  2008-01       Impact factor: 2.493

View more
  5 in total

1.  A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia.

Authors:  Marlise R Luskin; Phyllis A Gimotty; Catherine Smith; Alison W Loren; Maria E Figueroa; Jenna Harrison; Zhuoxin Sun; Martin S Tallman; Elisabeth M Paietta; Mark R Litzow; Ari M Melnick; Ross L Levine; Hugo F Fernandez; Selina M Luger; Martin Carroll; Stephen R Master; Gerald B W Wertheim
Journal:  JCI Insight       Date:  2016-06-16

2.  MAGPEL: an autoMated pipeline for inferring vAriant-driven Gene PanEls from the full-length biomedical literature.

Authors:  Nafiseh Saberian; Adib Shafi; Azam Peyvandipour; Sorin Draghici
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

3.  Up-regulation of EMT-related gene VCAN by NPM1 mutant-driven TGF-β/cPML signalling promotes leukemia cell invasion.

Authors:  Liyuan Yang; Lu Wang; Zailin Yang; Hongjun Jin; Qin Zou; Qian Zhan; Yuting Tang; Yao Tao; Li Lei; Yipei Jing; Xueke Jiang; Ling Zhang
Journal:  J Cancer       Date:  2019-10-21       Impact factor: 4.207

4.  Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field.

Authors:  Brunangelo Falini; Sofia Sciabolacci; Lorenza Falini; Lorenzo Brunetti; Maria Paola Martelli
Journal:  Leukemia       Date:  2021-04-20       Impact factor: 12.883

5.  Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling.

Authors:  Jingrong Xian; Huiyuan Shao; Xianchun Chen; Shuaishuai Zhang; Jing Quan; Qin Zou; Hongjun Jin; Ling Zhang
Journal:  Int J Biol Sci       Date:  2016-01-01       Impact factor: 6.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.